This company seems to have been delisted
Reason: Filed for bankruptcy
Last recorded trade on: October 20, 2023
Source: https://www.reuters.com/business/biotech-firm-amyris-files-bankruptcy-us-2023-08-10/
Reason: Filed for bankruptcy
Last recorded trade on: October 20, 2023
Source: https://www.reuters.com/business/biotech-firm-amyris-files-bankruptcy-us-2023-08-10/
Amyris
AMRS
$0.05000
Share price
0.00%
Change (1 day)
-97.22%
Change (1 year)
Amyris (AMRS) - P/B ratio
P/B ratio as of April 2025 : -0.0285
According to Amyris's latest financial reports the company has a price-to-book ratio of 0.0688585.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Amyris - P/B ratio (from 2010 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | -1.25 | -120.89% |
| 2021-12-31 | 5.97 | -165.96% |
| 2020-12-31 | -9.05 | 522.62% |
| 2019-12-31 | -1.45 | 20.46% |
| 2018-12-31 | -1.21 | 45.66% |
| 2017-12-31 | -0.8288 | -22.94% |
| 2016-12-31 | -1.08 | -48.96% |
| 2015-12-31 | -2.11 | 61.5% |
| 2014-12-31 | -1.30 | -56.29% |
| 2013-12-31 | -2.99 | -192.23% |
| 2012-12-31 | 3.24 | -0.98% |
| 2011-12-31 | 3.27 | -14.06% |
| 2010-12-31 | 3.80 | |
| 2009-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 | 1.33 | -4,776.69% | 🇺🇸 USA |
 | 0.6103 | -2,241.49% | 🇺🇸 USA |
 | 0.8385 | -3,042.27% | 🇺🇸 USA |
 | 0.2517 | -983.02% | 🇺🇸 USA |
 | 0.5874 | -2,161.17% | 🇺🇸 USA |
 | 1.06 | -3,811.74% | 🇺🇸 USA |